Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market
• Eli Lilly and Company is urging online platforms, payment processors, and regulators to dismantle the illegal black market for retatrutide. • Retatrutide is currently an investigational molecule in Phase 3 clinical trials for obesity and type 2 diabetes and has not been approved for human use by any global regulatory agency. • The company warns that "research-use only" products are of unknown quality and potentially harmful, noting that the FDA has declared the sale and compounding of the drug illegal.
prnewswire.com




